TETRALOGIC PHARMACEUTICALS CORP Proceeds from Convertible Debt
TETRALOGIC PHARMACEUTICALS CORP reported Proceeds from Convertible Debt of $44.15 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2016-03-16
- TETRALOGIC PHARMACEUTICALS CORP proceeds from convertible debt for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP proceeds from convertible debt for the quarter ending 2014-09-30 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP proceeds from convertible debt for the quarter ending 2013-12-31 was $6.24M.
- TETRALOGIC PHARMACEUTICALS CORP proceeds from convertible debt for the quarter ending 2013-09-30 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP proceeds from convertible debt for fiscal 2014 was $44.15M, a 210.12% increase from fiscal 2013.
- TETRALOGIC PHARMACEUTICALS CORP proceeds from convertible debt for fiscal 2013 was $14.24M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 126 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $0.00 derived: sum of 2 quarters · filed 2016-03-16 | $44.15M 10-K · filed 2016-03-16 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $44.15M 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | $44.15M 10-Q · filed 2015-08-05 | ||||
| 2014-03-31 | $24.76M 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $6.24M derived: sum of 2 quarters · filed 2015-02-26 | $14.24M 10-K · filed 2015-02-26 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $8.00M 10-Q · filed 2014-11-05 | |||
| 2013-06-30 | $8.00M 10-Q · filed 2014-08-05 |